14-3-3 protein has emerged as critical regulators of diverse cellular responses. Previous studies found that strong
14-3-3 protein expression was observed and associated with
tumor genesis and progression in
glioma. Here, we further elucidated the role of
14-3-3 protein in apoptosis of human
glioma U251 and U87 cells by global inhibition of 14-3-3 functions with a general 14-3-3 antagonist,
difopein. In vitro, morphological observation and
DNA laddering assay showed that
difopein-treated
glioma cells displayed outstanding apoptosis characteristics, such as nuclear fragmentation, appearance of membrane-enclosed apoptotic bodies and
DNA laddering fragment. Moreover, flow cytometric detection of
phosphatidylserine externalization indicated that
difopein-induced apoptosis occurred in a time-dependent manner. Interestingly, inhibiting 14-3-3 with small interfere
RNA also induce apoptosis of human
glioma U251 cells. Furthermore, RT-PCR and western blot assay further substantiated that
difopein had strong effects to induce
glioma cell apoptosis through down-regulating Bcl-2, up-regulating Bax and activating
caspase-9 and
caspase-3. In vivo, retroviral vector was constructed and retroviral-mediated transfer of
difopein to
glioma was implanted in nude mice.
Difopein effectively hindered proliferation and triggered apoptosis of
tumor cells implanted into nude mice. This work not only reveals a critical role of 14-3-3 in apoptosis suppression in
glioma cells, but also identifies and validates 14-3-3 as a potential molecular target for anticancer therapeutic development.